AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT05693142 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05693142
- Sponsor
- REGENXBIO Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-04
- Primary completion
- 2026-09-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.